MedTrace Logo

Effect of Highly Bioavailable Curcumin on Subjective Tinnitus

NCT04800107 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2023-04-20

No results posted yet for this study

Summary

This study will assess the effectiveness of highly bioavailable curcumin in suppressing subjective tinnitus based on pre- and post-treatment evaluations using the validated Tinnitus Functional Index (TFI) and Tinnitus Handicap Inventory (THI) surveys.

Conditions

  • Tinnitus, Subjective

Interventions

BIOLOGICAL

Curcumin-phosphatidylcholine

500 mg of curcumin-phosphatidylcholine combined with 250 mg of boswellia-phosphatidyl

BIOLOGICAL

Placebo capsule

Placebo capsule

Sponsors & Collaborators

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Seilish Babu, MD · Michigan Ear Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-06
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04800107 on ClinicalTrials.gov